Effect of Implant Thread Design on Implant Stability Quotient (ISQ) in Early Healing Period
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Mar 2, 2016
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Study Design/Sample. This study will be a prospective cohort study. The study sample will be derived from patients presenting to the study site in need of at least two dental implants and who satisfy the criteria listed below. The study site for this project will be University of California, Los Angeles (UCLA) Postgraduate Periodontics and Implant Surgery Clinic. Implant surgeries will be performed by postgraduate periodontal residents of this program. Any resident involved in this study will have had previous experience in placing dental implants. Also, the residents will be, at all times,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Missing two or more teeth with a desire to receive an implant-supported or implant-assisted tooth replacement
- • Healed maxillary or mandibular edentulous site for implant placement
- • Sufficient bone volume in the site to allow implant placement without the need for bone augmentation
- Exclusion Criteria:
- • Systemic disease, medication, or habit known to negatively influence bone healing and/or dental implant success
- • Poorly controlled diabetes (HbA1c \> 8%)
- • History of bisphosphonate use
- • History of head \& neck radiation therapy affecting the proposed implant site
- • History of smoking \>10 cigarettes/day (within past 12 months)
- • Current use of medications that adversely affect healing (e.g. corticosteroids, chemotherapeutic drugs)
- • Immune compromised condition (resulting from disease or treatment)
- • Insufficient bone volume for dental implant placement
- • Otherwise contraindicated to undergo periodontal / oral / implant surgery
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Perry R Klokkevold, DDS, MS
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials